James D. Clark - Dec 1, 2021 Form 4/A - Amendment Insider Report for CVS HEALTH Corp (CVS)

Role
SVP, Cont & Chief Acct Officer
Signature
/s/ James D. Clark
Stock symbol
CVS
Transactions as of
Dec 1, 2021
Transactions value $
-$23,615
Form type
4/A - Amendment
Date filed
10/14/2022, 05:52 PM
Date Of Original Report
Dec 3, 2021
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (restricted) Tax liability -$23.6K -266 -1.57% $88.78 16.7K Dec 1, 2021 Direct F1
holding CVS Common Stock 17.5K Dec 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 6.06K Dec 1, 2021 Common Stock 6.06K $102.26 Direct F2
holding CVS Stock Option 7.04K Dec 1, 2021 Common Stock 7.04K $104.82 Direct F3
holding CVS Stock Option 9.05K Dec 1, 2021 Common Stock 9.05K $78.05 Direct F4
holding CVS Stock Option 7.51K Dec 1, 2021 Common Stock 7.51K $62.21 Direct F5
holding CVS Stock Option 24.2K Dec 1, 2021 Common Stock 24.2K $54.19 Direct F6
holding CVS Stock Option 17.2K Dec 1, 2021 Common Stock 17.2K $58.34 Direct F7, F8
holding CVS Stock Option 12.1K Dec 1, 2021 Common Stock 12.1K $74.30 Direct F9
holding CVS Stock Option 0 Dec 1, 2021 Common Stock 0 $101.09 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible.
F2 Options became exercisable in four equal annual installments beginning on 4/1/2016.
F3 Options became exercisable in four equal annual installments beginning on 4/1/2017.
F4 Options became exercisable in four equal annual installments beginning on 4/3/2018.
F5 Options became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Options became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
F10 Option becomes exercisable in four equal installments, commencing 4/1/2023.